mozavaptan has been researched along with Body Weight in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanno, Y; Okada, H; Saruta, T; Suzuki, H | 2 |
| Arakawa, K; Ichihara, A; Matsumoto, A; Murakami, M; Naitoh, M; Nakamoto, H; Oka, K; Saruta, T; Suzuki, H; Yamamura, Y | 1 |
| Fujisawa, G; Ishikawa, S; Okada, K; Saito, T; Tsuboi, Y | 1 |
| Aldred, KL; Burrell, LM; Chan, RK; Johnston, CI; Phillips, PA; Risvanis, J | 1 |
| Arroyo, V; Bordas, N; Bosch-Marcé, M; Jiménez, W; Leivas, A; Morales-Ruiz, M; Muñoz, RM; Pérez, M; Poo, JL; Rivera, F; Rodés, J | 1 |
6 other study(ies) available for mozavaptan and Body Weight
| Article | Year |
|---|---|
Effect of nonpeptide vasopressin receptor antagonists on developing, and established DOCA-salt hypertension in rats.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Body Weight; Desoxycorticosterone; Hypertension; Male; Piperidines; Quinolones; Random Allocation; Rats; Rats, Wistar; Sodium Chloride | 1995 |
Effects of novel, nonpeptide vasopressin antagonists on progressive nephrosclerosis in rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Blood Pressure; Body Weight; Disease Models, Animal; Diuresis; Glomerulosclerosis, Focal Segmental; Hypertension; Kidney; Male; Nephrectomy; Nephrosclerosis; Piperidines; Proteinuria; Quinolones; Rats; Rats, Inbred SHR | 1995 |
Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Capillary Resistance; Cardiac Output; Cardiac Pacing, Artificial; Diuresis; Dogs; Heart Failure; Hemodynamics; Kidney; Male; Natriuresis; Osmolar Concentration; Piperidines; Potassium; Quinolones; Renin; Sodium | 1994 |
Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats.
Topics: Animals; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Weight; Diuresis; Glomerular Filtration Rate; Liver Cirrhosis, Experimental; Male; Osmolar Concentration; Rats; Rats, Wistar; Vasopressins; Water-Electrolyte Balance | 1994 |
Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Weight; Diuresis; Female; Heart; Heart Failure; Hemodynamics; Lung; Myocardial Infarction; Organ Size; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Survival Analysis; Systole | 1998 |
Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention.
Topics: Aldosterone; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Benzeneacetamides; Body Water; Body Weight; Carbon Tetrachloride Poisoning; Diuretics; Hemodynamics; Hormones; Hypothalamus; Kidney; Liver Cirrhosis, Experimental; Male; Osmolar Concentration; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa; RNA, Messenger; Urodynamics; Vasopressins | 1999 |